Session 2B: Radiopharmaceutical manufacturing in Australia
Tracks
Track 3
| Wednesday, October 22, 2025 |
| 2:50 PM - 3:35 PM |
Details
Australia is becoming a leader in radiopharmaceutical manufacturing, with a focus on developing and manufacturing the next generation of therapeutic radiopharmaceuticals, particularly for cancer treatment, and producing short-lived radioisotopes and radiopharmaceuticals for positron emission tomography (PET) scans.
This session brings together some key radiopharmaceuticals manufacturers from industry and research with the aim of positioning Australia as a world-leader in the field of radiopharmaceutical manufacture and innovation.
Speaker
Mr Chady Barkil
Director
South Australian Health and Medical Research Institute
Panellist
Sam Graf
Innovation and Partnerships Manager
Cyclotek Pty Ltd
Panellist
Dr Nat Lenzo
Founder and Managing Director
Cyclowest Pty Ltd
Panellist
Simone Leyden
Senior Director Global Public Affairs and Patient Advocacy
Telix Pharmaceuticals Limited
Panellist
